It is essential that there is open communication between everyone involved in a clinical trial. It is for that reason that the informed consent process is conducted by the PI or a trained associate. Each Research Subject is provided with phone numbers through which the PI or associate can be reached 24 hours each day, seven days of the week.

The Research Nurses and Project Coordinators have personal contact with the Research Subjects at each visit and determine if any difficulty was encountered since the last visit. Research Subjects are relied upon to follow the detailed instructions given to them and to report any deviation and any complication. Remember, the safety of all those who may use this drug or treatment in the future depends upon the accuracy of each Phase of the clinical research that leads to its approval.

Please feel free to contact the CTSI or Research Subject Safety Office staff if you have any questions or concerns regarding your treatment or the clinical trial you are participating in.

Contact Information

NYU-HHC Clinical Translational Science Institute

Nurse Manager
Eleanor DeCandia, RN
212-263-6411

Research Subject Safety Office
Halie Melnyk, RN
Eric Leibert, MD
212-263-2584
halia.melnyk@nyumc.org